Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 21,194 | 20,923 | 8,982 | 29 | 0 |
| Cost of Goods | 28,643 | 24,445 | 17,951 | N/A | N/A |
| Gross Profit | -7,449 | -3,522 | -8,969 | -11,358 | N/A |
| Operating Expenses | 64,815 | 58,140 | 57,222 | 75,893 | 67,876 |
| Operating Income | -71,621 | -61,217 | -65,240 | -75,864 | -67,876 |
| Interest Expense | 10,520 | -6,829 | 10,143 | -30,835 | 10,686 |
| Other Income | 3,555 | 6,868 | 7,447 | 18,886 | -3,510 |
| Pre-tax Income | -78,586 | -47,520 | -67,936 | -26,143 | -82,072 |
| Income Tax | 532 | 397 | 2,225 | 1,463 | 22 |
| Net Income Continuous | -79,118 | -47,917 | -70,161 | -27,606 | -82,094 |
| Net Income | $-79,118 | $-47,917 | $-70,161 | $-27,606 | $-82,094 |
| EPS Basic Total Ops | -0.30 | -0.18 | -0.26 | -0.09 | -0.31 |
| EPS Basic Continuous Ops | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 |
| EPS Diluted Total Ops | -0.30 | -0.18 | -0.26 | -0.09 | -0.31 |
| EPS Diluted Continuous Ops | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.18 | -0.26 | -0.09 | -0.31 |
| EBITDA(a) | $-69,083 | $-58,849 | $-62,963 | $-73,787 | $-65,938 |